Monitoring Multiple Myeloma

How Blood, Urine, and Imaging Tests Impact Treatment Decisions

Lab tests play a central role in diagnosing and managing multiple myeloma, yet they can feel confusing and overwhelming.

In this expert conversation, Dr. Brandon Blue of Moffitt Cancer Center sits down with Bryon Daily, a multiple myeloma patient and community leader from The Leukemia & Lymphoma Society, to break it all down in real terms.

Whether you’re newly diagnosed or have been living with multiple myeloma for years, this conversation is for you.

Program Topics

Imaging tests explained: X-ray, MRI, PET
Find out how lab work helps guide treatment decisions
What labs indicate a relapse or treatment change
Using biomarkers in clinical trials

Program Panel

Program Partners

Thank you to Blood Cancer United for their partnership. They are here for you with information about clinical trials, resources, and dedicated support through their Information Specialists.

From groundbreaking studies to insightful patient stories, MPN Research Foundation is at the forefront of making real change for those directly affected by essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).

This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

This interview has been edited for clarity and length. The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story. This content does not replace professional medical advice.